310 related articles for article (PubMed ID: 23630258)
1. Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics.
Zhu G; Zheng J; Song E; Donovan M; Zhang K; Liu C; Tan W
Proc Natl Acad Sci U S A; 2013 May; 110(20):7998-8003. PubMed ID: 23630258
[TBL] [Abstract][Full Text] [Related]
2. High payload and targeted release of anthracyclines by aptamer-tethered DNA nanotrains - Thermodynamic and release kinetic study.
Pei W; Liu M; Wu Y; Zhao Y; Liu T; Sun B; Liu Y; Wang Q; Han J
Eur J Pharm Sci; 2020 May; 148():105319. PubMed ID: 32205231
[TBL] [Abstract][Full Text] [Related]
3. A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy.
Zhang L; Wang M; Zhu Z; Ding C; Chen S; Wu H; Yang Y; Che F; Li Q; Li H
Int J Nanomedicine; 2021; 16():3217-3240. PubMed ID: 34007175
[TBL] [Abstract][Full Text] [Related]
4. Self-Assembled DNA-Protein Hybrid Nanospheres: Biocompatible Nano-Drug-Carriers for Targeted Cancer Therapy.
Lee D; Baek S; Kim YY; Bang Y; Jung HN; Im HJ; Song YK
ACS Appl Mater Interfaces; 2022 Aug; 14(33):37493-37503. PubMed ID: 35969502
[TBL] [Abstract][Full Text] [Related]
5. Precision-Guided Missile-Like DNA Nanostructure Containing Warhead and Guidance Control for Aptamer-Based Targeted Drug Delivery into Cancer Cells in Vitro and in Vivo.
Ouyang C; Zhang S; Xue C; Yu X; Xu H; Wang Z; Lu Y; Wu ZS
J Am Chem Soc; 2020 Jan; 142(3):1265-1277. PubMed ID: 31895985
[TBL] [Abstract][Full Text] [Related]
6. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery.
Zhang H; Ma Y; Xie Y; An Y; Huang Y; Zhu Z; Yang CJ
Sci Rep; 2015 May; 5():10099. PubMed ID: 25959874
[TBL] [Abstract][Full Text] [Related]
7. Aptamer CaCO3 nanostructures: a facile, pH-responsive, specific platform for targeted anticancer theranostics.
Zhou C; Chen T; Wu C; Zhu G; Qiu L; Cui C; Hou W; Tan W
Chem Asian J; 2015 Jan; 10(1):166-71. PubMed ID: 25377905
[TBL] [Abstract][Full Text] [Related]
8. DNA nanotriangle-scaffolded activatable aptamer probe with ultralow background and robust stability for cancer theranostics.
Lei Y; Qiao Z; Tang J; He X; Shi H; Ye X; Yan L; He D; Wang K
Theranostics; 2018; 8(15):4062-4071. PubMed ID: 30128036
[TBL] [Abstract][Full Text] [Related]
9. DNA Polymer Nanoparticles Programmed via Supersandwich Hybridization for Imaging and Therapy of Cancer Cells.
Li N; Xiang MH; Liu JW; Tang H; Jiang JH
Anal Chem; 2018 Nov; 90(21):12951-12958. PubMed ID: 30303006
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-based nanotrains and nanoflowers as quinine delivery systems.
Cao M; Vial A; Minder L; Guédin A; Fribourg S; Azéma L; Feuillie C; Molinari M; Di Primo C; Barthélémy P; Jeanne LC
Int J Pharm X; 2023 Dec; 5():100172. PubMed ID: 36861067
[TBL] [Abstract][Full Text] [Related]
11. Bioinspired DNA nanocockleburs for targeted delivery of doxorubicin.
Sun S; Cheraga N; Jiang HN; Xiao QR; Gao PC; Wang Y; Wei YY; Wang XW; Jiang Y
Colloids Surf B Biointerfaces; 2020 Feb; 186():110733. PubMed ID: 31864113
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
Zhu H; Li J; Zhang XB; Ye M; Tan W
ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembled DNA Nanocentipede as Multivalent Drug Carrier for Targeted Delivery.
Li W; Yang X; He L; Wang K; Wang Q; Huang J; Liu J; Wu B; Xu C
ACS Appl Mater Interfaces; 2016 Oct; 8(39):25733-25740. PubMed ID: 27622459
[TBL] [Abstract][Full Text] [Related]
14. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
Xiang D; Zheng C; Zhou SF; Qiao S; Tran PH; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W
Theranostics; 2015; 5(10):1083-97. PubMed ID: 26199647
[TBL] [Abstract][Full Text] [Related]
15. Nature-Inspired Smart DNA Nanodoctor for Activatable In Vivo Cancer Imaging and In Situ Drug Release Based on Recognition-Triggered Assembly of Split Aptamer.
Lei Y; Tang J; Shi H; Ye X; He X; Xu F; Yan L; Qiao Z; Wang K
Anal Chem; 2016 Dec; 88(23):11699-11706. PubMed ID: 27807977
[TBL] [Abstract][Full Text] [Related]
16. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
17. Self-Assembled Supramolecular Nanoparticles for Targeted Delivery and Combination Chemotherapy.
Li B; Feng Z; He L; Li W; Wang Q; Liu J; Huang J; Zheng Y; Ma Y; Yang X; Wang K
ChemMedChem; 2018 Oct; 13(19):2037-2044. PubMed ID: 30024095
[TBL] [Abstract][Full Text] [Related]
18. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
[TBL] [Abstract][Full Text] [Related]
19. Programmable Self-Assembly of Protein-Scaffolded DNA Nanohydrogels for Tumor-Targeted Imaging and Therapy.
Li N; Wang XY; Xiang MH; Liu JW; Yu RQ; Jiang JH
Anal Chem; 2019 Feb; 91(4):2610-2614. PubMed ID: 30701962
[TBL] [Abstract][Full Text] [Related]
20. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
